kuro health limited
kuro health limited Company Information
Company Number
09941789
Next Accounts
Sep 2025
Shareholders
henry otto brunjes
jacqueline mary brunjes
View AllGroup Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
4th floor, park gate 161-163, preston road, brighton, east sussex, BN1 6AF
Website
https://www.capita.comkuro health limited Estimated Valuation
Pomanda estimates the enterprise value of KURO HEALTH LIMITED at £94m based on a Turnover of £47.7m and 1.97x industry multiple (adjusted for size and gross margin).
kuro health limited Estimated Valuation
Pomanda estimates the enterprise value of KURO HEALTH LIMITED at £24.7m based on an EBITDA of £3m and a 8.18x industry multiple (adjusted for size and gross margin).
kuro health limited Estimated Valuation
Pomanda estimates the enterprise value of KURO HEALTH LIMITED at £26.8m based on Net Assets of £19.9m and 1.34x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Kuro Health Limited Overview
Kuro Health Limited is a live company located in brighton, BN1 6AF with a Companies House number of 09941789. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in January 2016, it's largest shareholder is henry otto brunjes with a 26.9% stake. Kuro Health Limited is a young, large sized company, Pomanda has estimated its turnover at £47.7m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Kuro Health Limited Health Check
Pomanda's financial health check has awarded Kuro Health Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
3 Strong
4 Regular
4 Weak
Size
annual sales of £47.7m, make it larger than the average company (£18.9m)
£47.7m - Kuro Health Limited
£18.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (10.5%)
-4% - Kuro Health Limited
10.5% - Industry AVG
Production
with a gross margin of 22.9%, this company has a higher cost of product (36.3%)
22.9% - Kuro Health Limited
36.3% - Industry AVG
Profitability
an operating margin of 5.1% make it as profitable than the average company (4.5%)
5.1% - Kuro Health Limited
4.5% - Industry AVG
Employees
with 261 employees, this is above the industry average (104)
261 - Kuro Health Limited
104 - Industry AVG
Pay Structure
on an average salary of £43.6k, the company has an equivalent pay structure (£44.7k)
£43.6k - Kuro Health Limited
£44.7k - Industry AVG
Efficiency
resulting in sales per employee of £182.8k, this is equally as efficient (£191.6k)
£182.8k - Kuro Health Limited
£191.6k - Industry AVG
Debtor Days
it gets paid by customers after 439 days, this is later than average (45 days)
439 days - Kuro Health Limited
45 days - Industry AVG
Creditor Days
its suppliers are paid after 104 days, this is slower than average (44 days)
104 days - Kuro Health Limited
44 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Kuro Health Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (14 weeks)
0 weeks - Kuro Health Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 68%, this is a similar level of debt than the average (69.6%)
68% - Kuro Health Limited
69.6% - Industry AVG
KURO HEALTH LIMITED financials
Kuro Health Limited's latest turnover from December 2023 is £47.7 million and the company has net assets of £19.9 million. According to their latest financial statements, Kuro Health Limited has 261 employees and maintains cash reserves of £489.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 47,700,985 | 51,356,715 | 45,286,646 | 53,531,108 | 39,968,000 | 37,159,891 | 34,272,956 | 17,536,630 |
| Other Income Or Grants | ||||||||
| Cost Of Sales | 36,799,470 | 40,001,435 | 34,690,622 | 40,336,019 | 29,694,000 | 27,284,234 | 22,680,221 | 13,654,598 |
| Gross Profit | 10,901,515 | 11,355,280 | 10,596,024 | 13,195,089 | 10,274,000 | 9,875,657 | 11,592,735 | 3,882,032 |
| Admin Expenses | 8,463,857 | 9,324,260 | 8,770,041 | 11,940,612 | 6,265,000 | 5,881,980 | 8,175,616 | -7,374,896 |
| Operating Profit | 2,437,658 | 2,031,020 | 1,825,983 | 1,254,477 | 4,009,000 | 3,993,677 | 3,417,119 | 11,256,928 |
| Interest Payable | 1,325,754 | 818,360 | 459,742 | 461,508 | 298,000 | 401,912 | 521,836 | 267,945 |
| Interest Receivable | 490 | 161 | 97 | 25,684 | ||||
| Pre-Tax Profit | 1,186,040 | -383,598 | 1,366,338 | 818,653 | 3,718,000 | 3,591,765 | 2,895,144 | 10,988,983 |
| Tax | -390,132 | 794 | -179,809 | -234,220 | -478,000 | -627,713 | -609,277 | -30,866 |
| Profit After Tax | 795,908 | -382,804 | 1,186,529 | 584,433 | 3,240,000 | 2,964,052 | 2,285,867 | 10,958,117 |
| Dividends Paid | 500,000 | |||||||
| Retained Profit | 795,908 | -382,804 | 1,186,529 | 84,433 | 3,240,000 | 2,964,052 | 2,285,867 | 10,948,621 |
| Employee Costs | 11,370,216 | 11,567,399 | 10,216,274 | 12,283,373 | 8,258,000 | 7,083,276 | 5,978,930 | 3,747,235 |
| Number Of Employees | 261 | 341 | 329 | 285 | 296 | 300 | 241 | 227 |
| EBITDA* | 3,020,600 | 2,771,678 | 2,835,540 | 1,985,571 | 4,420,000 | 4,269,824 | 3,542,277 | 22,495,033 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 342,223 | 410,251 | 544,941 | 455,056 | 369,000 | 646,155 | 1,238,670 | 1,941,961 |
| Intangible Assets | 763,160 | 2,140,846 | 4,180,353 | 3,184,219 | 2,773,000 | 2,643,315 | 341,880 | 4,000 |
| Investments & Other | ||||||||
| Debtors (Due After 1 year) | 27,516 | 50,355 | 6,017 | 46,185 | 47,000 | 404,147 | 1,059,173 | |
| Total Fixed Assets | 1,132,899 | 2,601,452 | 4,731,311 | 3,685,460 | 3,189,000 | 3,289,470 | 1,580,550 | 1,945,961 |
| Stock & work in progress | ||||||||
| Trade Debtors | 57,419,611 | 58,177,261 | 48,982,507 | 35,183,394 | 35,533,000 | 38,663,814 | 38,899,860 | 40,967,815 |
| Group Debtors | ||||||||
| Misc Debtors | 3,229,134 | 3,566,546 | 3,438,923 | 3,601,980 | 5,145,000 | 3,076,041 | 3,043,950 | 4,116,333 |
| Cash | 489,785 | 272,455 | 895,104 | 384,623 | 958,000 | 779,759 | 940,088 | 1,973,653 |
| misc current assets | ||||||||
| total current assets | 61,138,530 | 62,016,262 | 53,316,534 | 39,169,997 | 41,636,000 | 42,519,614 | 42,883,898 | 47,057,801 |
| total assets | 62,271,429 | 64,617,714 | 58,047,845 | 42,855,457 | 44,825,000 | 45,809,084 | 44,464,448 | 49,003,762 |
| Bank overdraft | 12,669,145 | 15,376,625 | ||||||
| Bank loan | 13,498,105 | 8,129,499 | 6,202,829 | |||||
| Trade Creditors | 10,567,074 | 10,606,889 | 9,022,605 | 4,080,037 | 4,694,000 | 5,204,097 | 4,335,838 | 4,376,206 |
| Group/Directors Accounts | ||||||||
| other short term finances | 10,842,000 | |||||||
| hp & lease commitments | 87,855 | |||||||
| other current liabilities | 16,787,421 | 16,666,418 | 12,931,285 | 8,885,700 | 9,655,000 | 11,846,521 | 12,735,842 | 13,401,538 |
| total current liabilities | 40,111,495 | 42,649,932 | 35,451,995 | 21,095,236 | 25,191,000 | 23,253,447 | 17,071,680 | 17,777,744 |
| loans | 2,051,202 | 2,635,336 | 2,750,000 | 2,025,000 | 6,186,097 | 14,000,000 | 20,000,000 | |
| hp & lease commitments | 11,878 | |||||||
| Accruals and Deferred Income | ||||||||
| other liabilities | ||||||||
| provisions | 147,000 | 178,500 | 309,100 | 210,000 | 195,000 | 340,000 | 314,560 | 321,396 |
| total long term liabilities | 2,210,080 | 2,813,836 | 3,059,100 | 2,235,000 | 195,000 | 6,356,097 | 14,157,280 | 20,160,698 |
| total liabilities | 42,321,575 | 45,463,768 | 38,511,095 | 23,330,236 | 25,386,000 | 29,609,544 | 31,228,960 | 37,938,442 |
| net assets | 19,949,854 | 19,153,946 | 19,536,750 | 19,525,221 | 19,439,000 | 16,199,540 | 13,235,488 | 10,949,621 |
| total shareholders funds | 19,949,854 | 19,153,946 | 19,536,750 | 19,525,221 | 19,439,000 | 16,199,540 | 13,235,488 | 10,949,621 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | 2,437,658 | 2,031,020 | 1,825,983 | 1,254,477 | 4,009,000 | 3,993,677 | 3,417,119 | 11,256,928 |
| Depreciation | 146,547 | 206,465 | 189,744 | 163,858 | 101,000 | 128,188 | 125,158 | 61,919 |
| Amortisation | 436,395 | 534,193 | 819,813 | 567,236 | 310,000 | 147,959 | 11,176,186 | |
| Tax | -390,132 | 794 | -179,809 | -234,220 | -478,000 | -627,713 | -609,277 | -30,866 |
| Stock | ||||||||
| Debtors | -1,117,901 | 9,366,715 | 13,595,888 | -1,893,441 | -1,419,002 | -858,981 | -2,081,165 | 45,084,148 |
| Creditors | -39,815 | 1,584,284 | 4,942,568 | -613,963 | -510,097 | 868,259 | -40,368 | 4,376,206 |
| Accruals and Deferred Income | 121,003 | 3,735,133 | 4,045,585 | -769,300 | -2,191,521 | -889,321 | -665,696 | 13,401,538 |
| Deferred Taxes & Provisions | -31,500 | -130,600 | 99,100 | 15,000 | -145,000 | 25,440 | -6,836 | 321,396 |
| Cash flow from operations | 3,798,057 | -1,405,426 | -1,852,904 | 2,276,529 | 2,514,384 | 4,505,470 | 4,301,265 | -4,520,841 |
| Investing Activities | ||||||||
| capital expenditure | -1,859,000 | |||||||
| Change in Investments | ||||||||
| cash flow from investments | -1,859,000 | |||||||
| Financing Activities | ||||||||
| Bank loans | -13,498,105 | 5,368,606 | 8,129,499 | -6,202,829 | 6,202,829 | |||
| Group/Directors Accounts | ||||||||
| Other Short Term Loans | -10,842,000 | 10,842,000 | ||||||
| Long term loans | -584,134 | -114,664 | 725,000 | 2,025,000 | -6,186,097 | -7,813,903 | -6,000,000 | 20,000,000 |
| Hire Purchase and Lease Commitments | 99,733 | |||||||
| other long term liabilities | ||||||||
| share issue | ||||||||
| interest | -1,325,264 | -818,199 | -459,645 | -435,824 | -298,000 | -401,912 | -521,836 | -267,945 |
| cash flow from financing | -1,809,665 | -14,430,968 | 4,458,961 | -1,121,537 | -1,845,466 | -2,012,986 | -6,521,836 | 19,733,055 |
| cash and cash equivalents | ||||||||
| cash | 217,330 | -622,649 | 510,481 | -573,377 | 178,241 | -160,329 | -1,033,565 | 1,973,653 |
| overdraft | -2,707,480 | 15,376,625 | ||||||
| change in cash | 2,924,810 | -15,999,274 | 510,481 | -573,377 | 178,241 | -160,329 | -1,033,565 | 1,973,653 |
kuro health limited Credit Report and Business Information
Kuro Health Limited Competitor Analysis
Perform a competitor analysis for kuro health limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other large companies, companies in BN1 area or any other competitors across 12 key performance metrics.
kuro health limited Ownership
KURO HEALTH LIMITED group structure
Kuro Health Limited has 9 subsidiary companies.
Ultimate parent company
KURO HEALTH LIMITED
09941789
9 subsidiaries
kuro health limited directors
Kuro Health Limited currently has 7 directors. The longest serving directors include Dr Henry Brunjes (Jan 2016) and Mr Timothy Aspinall (Jan 2016).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Henry Brunjes | England | 70 years | Jan 2016 | - | Director |
| Mr Timothy Aspinall | England | 68 years | Jan 2016 | - | Director |
| Ms Jacqueline Brunjes | 66 years | Dec 2019 | - | Director | |
| Mr Barry Gray | England | 49 years | Jul 2020 | - | Director |
| Mr Gavin Sampson | England | 38 years | Jul 2020 | - | Director |
| Mr Barry Gray | England | 49 years | Jul 2020 | - | Director |
| Mr John Warner | 73 years | Dec 2024 | - | Director |
P&L
December 2023turnover
47.7m
-7%
operating profit
2.4m
+20%
gross margin
22.9%
+3.36%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
19.9m
+0.04%
total assets
62.3m
-0.04%
cash
489.8k
+0.8%
net assets
Total assets minus all liabilities
kuro health limited company details
company number
09941789
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
January 2016
age
9
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
premier medical holdings limited (February 2021)
accountant
-
auditor
PRICE BAILEY LLP
address
4th floor, park gate 161-163, preston road, brighton, east sussex, BN1 6AF
Bank
-
Legal Advisor
-
kuro health limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to kuro health limited. Currently there are 0 open charges and 2 have been satisfied in the past.
kuro health limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for KURO HEALTH LIMITED. This can take several minutes, an email will notify you when this has completed.
kuro health limited Companies House Filings - See Documents
| date | description | view/download |
|---|
